GS-326

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameGS-326

Drug Alias NameGS-326GS-326C

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionAngiogenesis inhibitorsAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGene Signal

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGene Signal

Active IndicationsN/A

Inactive IndicationsPancreatic Neoplasms

ATC CodeN/A